首页 > 最新文献

Journal of medicine and healthcare最新文献

英文 中文
Treatment Outcome Following Closed and Open Reduction of Condylar Fractures – A 3 Year Clinical Prospective Study 髁突骨折闭合性和开放性复位术后的治疗效果——一项为期3年的前瞻性临床研究
Pub Date : 2023-04-30 DOI: 10.47363/jmhc/2023(5)230
M. Mulla, Anupama Mudhol
In maxillofacial trauma patients mandibular fractures are more common, among which condylar region is the most frequent site of fracture accounting for 25-30%. Management of Condylar fracture is most controversial topic in maxillofacial trauma. This study is aimed at comparing the outcome of closed and open reduction of condylar fractures.
在颌面创伤患者中,下颌骨骨折较为常见,其中髁突区是最常见的骨折部位,占25-30%。髁突骨折的治疗是颌面部创伤中最具争议的话题。本研究旨在比较闭合复位和开放复位治疗髁突骨折的疗效。
{"title":"Treatment Outcome Following Closed and Open Reduction of Condylar Fractures – A 3 Year Clinical Prospective Study","authors":"M. Mulla, Anupama Mudhol","doi":"10.47363/jmhc/2023(5)230","DOIUrl":"https://doi.org/10.47363/jmhc/2023(5)230","url":null,"abstract":"In maxillofacial trauma patients mandibular fractures are more common, among which condylar region is the most frequent site of fracture accounting for 25-30%. Management of Condylar fracture is most controversial topic in maxillofacial trauma. This study is aimed at comparing the outcome of closed and open reduction of condylar fractures.","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48448172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feedback from an Adverse Event Associated with Medication Error Type Care. Case of the Saint Padre Pio Hospital Centre in Lubumbashi in the Democratic Republic of Congo 与用药错误类型护理相关的不良事件反馈。刚果民主共和国卢本巴希圣帕德比奥医院中心的案例
Pub Date : 2023-03-31 DOI: 10.47363/jmhc/2023(5)228
Frank Nduu Nawej
During a recent routine vaccination session for children aged 0 to 11 months at the Padre Pio hospital center in Lubumbashi, a midwife administered twice the dose of the same injectable poliomyelitis vaccine (IPV) to an infant while only one dose was indicated. The child subsequently presented with some digestive disorders such as vomiting and diarrhea that required 24-hour observation in the emergency reception unit. The occurrence of this incident required the holding of a meeting with the various stakeholders. The aim was to examine the possible cause(s) of this incident, to be able to determine whether it was a fault attributable to the vaccinator or whether it was a systemic problem, the aim being to improve the safety of the practice of vaccination by preventing the occurrence of similar situations.
最近在卢本巴希的Padre Pio医院中心为0至11个月的儿童进行常规疫苗接种期间,一名助产士向一名婴儿注射了两剂相同的脊髓灰质炎注射疫苗(IPV),而只指示注射一剂。儿童随后出现一些消化系统紊乱,如呕吐和腹泻,需要在急诊接待室进行24小时观察。这一事件的发生需要与各利益相关者举行会议。目的是检查该事件的可能原因,以便能够确定这是可归因于接种人员的错误还是系统问题,目的是通过防止类似情况的发生来提高疫苗接种实践的安全性。
{"title":"Feedback from an Adverse Event Associated with Medication Error Type Care. Case of the Saint Padre Pio Hospital Centre in Lubumbashi in the Democratic Republic of Congo","authors":"Frank Nduu Nawej","doi":"10.47363/jmhc/2023(5)228","DOIUrl":"https://doi.org/10.47363/jmhc/2023(5)228","url":null,"abstract":"During a recent routine vaccination session for children aged 0 to 11 months at the Padre Pio hospital center in Lubumbashi, a midwife administered twice the dose of the same injectable poliomyelitis vaccine (IPV) to an infant while only one dose was indicated. The child subsequently presented with some digestive disorders such as vomiting and diarrhea that required 24-hour observation in the emergency reception unit. The occurrence of this incident required the holding of a meeting with the various stakeholders. The aim was to examine the possible cause(s) of this incident, to be able to determine whether it was a fault attributable to the vaccinator or whether it was a systemic problem, the aim being to improve the safety of the practice of vaccination by preventing the occurrence of similar situations.","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46552767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Constitutional Violations by the Health Care Quality Improvement Act (HCQIA) and the Reporting by the National Practitioner Databank (NPDB): Focusing on the Preservation of the Civil Rights of Physicians 《卫生保健质量改进法》的违宪行为和国家执业医师数据库的报告:侧重于维护医生的公民权利
Pub Date : 2023-03-31 DOI: 10.47363/jmhc/2023(5)227
Farid Gharagozloo, Robert Poston
In 1986, the US Congress passed the Health Care Quality Improvement Act of 1986. (HCQIA) was designed to protect the health and safety of the public by 1) enhancing the Peer Review process through protection for peer review members from lawsuits, and 2) providing a national repository for reported information regarding medical malpractice payments and adverse actions involving physicians, which among other things, would monitor the movement of incompetent or unprofessional physicians. The framers of HCQIA did not foresee that in 2023, hospitals and employers will invariably deny employment and/or hospital privileges based on an NPDB report outlining loss of hospital privileges or relinquishment of hospital privileges under investigation. Such an adverse report by NPDB results in the inability of the physician to obtain employment or practice in a hospital. Therefore, in 2023, the unintended consequence of the reporting of adverse peer review actions by NPDB, an agency of the Federal Government, can violate the constitutional and civil rights of the said physicians.
1986年,美国国会通过了《1986年医疗质量改善法案》。(HCQIA)旨在通过以下方式保护公众的健康和安全:1)通过保护同行评议成员免受诉讼来加强同行评议过程;2)提供一个关于医疗事故付款和涉及医生的不利行为的报告信息的国家存储库,除其他外,该存储库将监测不称职或不专业的医生的流动。HCQIA的制定者没有预见到,在2023年,根据NPDB的一份报告,医院和雇主将不可避免地拒绝雇佣和/或医院特权,该报告概述了医院特权的丧失或在调查中放弃医院特权。NPDB的这种不利报告导致医生无法在医院就业或执业。因此,在2023年,联邦政府机构NPDB报告不利同行评议行为的意外后果可能会侵犯上述医生的宪法和公民权利。
{"title":"Constitutional Violations by the Health Care Quality Improvement Act (HCQIA) and the Reporting by the National Practitioner Databank (NPDB): Focusing on the Preservation of the Civil Rights of Physicians","authors":"Farid Gharagozloo, Robert Poston","doi":"10.47363/jmhc/2023(5)227","DOIUrl":"https://doi.org/10.47363/jmhc/2023(5)227","url":null,"abstract":"In 1986, the US Congress passed the Health Care Quality Improvement Act of 1986. (HCQIA) was designed to protect the health and safety of the public by 1) enhancing the Peer Review process through protection for peer review members from lawsuits, and 2) providing a national repository for reported information regarding medical malpractice payments and adverse actions involving physicians, which among other things, would monitor the movement of incompetent or unprofessional physicians. The framers of HCQIA did not foresee that in 2023, hospitals and employers will invariably deny employment and/or hospital privileges based on an NPDB report outlining loss of hospital privileges or relinquishment of hospital privileges under investigation. Such an adverse report by NPDB results in the inability of the physician to obtain employment or practice in a hospital. Therefore, in 2023, the unintended consequence of the reporting of adverse peer review actions by NPDB, an agency of the Federal Government, can violate the constitutional and civil rights of the said physicians.","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135877547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Hepatitis C Treatment on Risk of Developing Cardiovascular Disease and Cardiac Arrhythmias 丙型肝炎治疗对心血管疾病和心律失常风险的影响
Pub Date : 2023-02-28 DOI: 10.47363/jmhc/2023(5)222
Annaporna Singh, Daulath Singh
Background: Chronic hepatitis C virus (HCV) infection affects more than 70 million people worldwide, is a systemic disease and has been implicated as a risk factor for cardiovascular disease (CVD). Objective: We sought to study the association between risk of CVD between 0-12 month and 12-24 months of HCV treatment initiation. Methods: 567,956 Hepatitis C patients without prior history of CVD were identified in the Cerner Health Facts database. Of these, 1446 patients received HCV treatment. We included both demographic and as covariates in the multivariate logistic regression model. To control for baseline differences among treatment and control groups, propensity score matching (PSM) comparative analysis was used to adjust for potential confounding baseline characteristics between these two groups, and finally 2892 patients (1:1 match) (1446 in each group) were enrolled in the final analysis. Results: There was no statistically significant association between CVD and treatment of HCV (at both 0-12 and 12-24 months). The odds of developing CVD for females were 1.52 times greater than males during the first 12 months of treatment. Advanced age was also associated with a high risk of CVD during the initial 12 months (OR 1.05 95% CI 1.03-1.07). HCV patients with HIV were 45% less likely to experience CVD Expanded =0.55, 95% CI: 0.33- 0.91, p<0.05) compared to those without HIV for 12-24 months. Treatment’s association with the development of cardiac arrhythmias was not statistically significant between 0-12 months or 12-24 months. Older age was associated with a higher risk of cardiac arrhythmias following 0-12 months after treatment with OR 1.08 95% CI 1.04-1.12. There was also a significantly high risk of arrhythmias with hypothyroidism for 0-12 months (OR 4.23 95% CI 1.48-12.08) Conclusion: Female sex and advanced age were associated with increased odds of CVD, and advanced age and hypothyroidism were associated with increased odds of arrhythmias development during the first 12 months of treatment. Further studies are needed to explore this in a prospective fashion.
背景:慢性丙型肝炎病毒(HCV)感染影响着全球7000多万人,是一种系统性疾病,被认为是心血管疾病(CVD)的危险因素。目的:我们试图研究在HCV治疗开始的0-12个月和12-24个月之间CVD风险之间的关系。方法:在Cerner Health Facts数据库中确定567956名既往无心血管疾病史的丙型肝炎患者。其中1446名患者接受了丙型肝炎病毒治疗。我们将人口统计学和作为协变量纳入多元逻辑回归模型。为了控制治疗组和对照组之间的基线差异,使用倾向评分匹配(PSM)比较分析来调整这两组之间潜在的混杂基线特征,最终2892名患者(1:1匹配)(每组1446人)被纳入最终分析。结果:CVD与HCV治疗(0-12个月和12-24个月)之间没有统计学意义的相关性。在治疗的前12个月,女性患心血管疾病的几率是男性的1.52倍。在最初的12个月内,高龄也与心血管疾病的高风险相关(OR 1.05,95%CI 1.03-1.07)。与未感染HIV的患者相比,感染HIV的HCV患者在12-24个月内发生心血管疾病的可能性降低45%(扩展=0.55,95%CI:0.33-0.91,p<0.05)。治疗与心律失常发展的相关性在0-12个月或12-24个月之间没有统计学意义。OR 1.08 95%CI 1.04-1.12治疗后0-12个月,年龄越大,心律失常的风险越高。在0-12个月内,甲状腺功能减退引起心律失常的风险也显著较高(OR 4.23 95%CI 1.48-12.08)。结论:女性和高龄与心血管疾病的发病几率增加有关,而在治疗的前12个月,高龄和甲状腺功能减退与心律失常发生几率增加有关。需要进一步的研究来前瞻性地探索这一点。
{"title":"Effect of Hepatitis C Treatment on Risk of Developing Cardiovascular Disease and Cardiac Arrhythmias","authors":"Annaporna Singh, Daulath Singh","doi":"10.47363/jmhc/2023(5)222","DOIUrl":"https://doi.org/10.47363/jmhc/2023(5)222","url":null,"abstract":"Background: Chronic hepatitis C virus (HCV) infection affects more than 70 million people worldwide, is a systemic disease and has been implicated as a risk factor for cardiovascular disease (CVD). Objective: We sought to study the association between risk of CVD between 0-12 month and 12-24 months of HCV treatment initiation. Methods: 567,956 Hepatitis C patients without prior history of CVD were identified in the Cerner Health Facts database. Of these, 1446 patients received HCV treatment. We included both demographic and as covariates in the multivariate logistic regression model. To control for baseline differences among treatment and control groups, propensity score matching (PSM) comparative analysis was used to adjust for potential confounding baseline characteristics between these two groups, and finally 2892 patients (1:1 match) (1446 in each group) were enrolled in the final analysis. Results: There was no statistically significant association between CVD and treatment of HCV (at both 0-12 and 12-24 months). The odds of developing CVD for females were 1.52 times greater than males during the first 12 months of treatment. Advanced age was also associated with a high risk of CVD during the initial 12 months (OR 1.05 95% CI 1.03-1.07). HCV patients with HIV were 45% less likely to experience CVD Expanded =0.55, 95% CI: 0.33- 0.91, p<0.05) compared to those without HIV for 12-24 months. Treatment’s association with the development of cardiac arrhythmias was not statistically significant between 0-12 months or 12-24 months. Older age was associated with a higher risk of cardiac arrhythmias following 0-12 months after treatment with OR 1.08 95% CI 1.04-1.12. There was also a significantly high risk of arrhythmias with hypothyroidism for 0-12 months (OR 4.23 95% CI 1.48-12.08) Conclusion: Female sex and advanced age were associated with increased odds of CVD, and advanced age and hypothyroidism were associated with increased odds of arrhythmias development during the first 12 months of treatment. Further studies are needed to explore this in a prospective fashion.","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43392818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of Information Printed on The Blister Pack of Loxoprofen Sodium Tablets 洛索洛芬钠片吸塑包装上印刷信息的调查
Pub Date : 2023-02-28 DOI: 10.47363/jmhc/2023(5)223
H. Houchi, Yuuri Houchi
Introduction: Loxoprofen sodium was selected as a commonly used medicine. The loxoprofen sodium tablets are marketed by 22 companies in Japan. The 22 different packaging types for this single active ingredient are served. We investigated the specifications printed on the 10-tablet blister pack. Methods: Regarding specifications printing, using the 22 loxoprofen sodium products, the survey items included how many times each of the specific printing was printed on the 10-tablet blister pack. About the questionnaire survey, a question I assessed the desired number of specifications. Question II assessed the direct printing of the drug name on each of the tablets and the size of tablet. The target population of the survey consisted of prescribing doctors, nurses, pharmacists, and non-healthcare workers. Result: The number of instances in which the drug name was listed ranged from 3 to 22 on the 10-tablet blister pack. The tablet identification code was printed ranged 0 - 10. Eleven products had no medical effect information on the pack. The expiration date was printed on two products. The serial number was not printed on one product. On the questionnaire survey, the desired number of instances that the standard dose was printed was significantly higher for nurses and pharmacists than for prescribing doctors and non-healthcare workers. Nurses considered information about medical effects to be important. Pharmacists demanded more barcodes. Several identification codes were requested by health care professionals. Although many of the tablets were 9 mm in size, the respondents desired smaller tablets. Conclusion: There were gaps between the amount of information printed on the pack and that was considered desirable by healthcare professionals and non-healthcare workers. Our findings indicate that multiple items are considered useful for developing packages for oral drugs marketed in the future as well as in ensuring safe and secure pharmacological therapy
简介:洛索洛芬钠被选为常用药物。洛索洛芬钠片剂由日本22家公司销售。该单一活性成分的22种不同包装类型提供。我们调查了印在10片泡罩包装上的规格。方法:关于规格印刷,使用22种洛索洛芬钠产品,调查项目包括每种特定印刷在10片泡罩包装上印刷多少次。关于问卷调查,我评估了一个问题所需的规格数量。问题二评估了在每片药片上直接打印药品名称和药片大小。调查的目标人群包括处方医生、护士、药剂师和非医护人员。结果:10片泡罩包装上列出药品名称的次数从3次到22次不等。平板电脑识别码的打印范围为0-10。11种产品的包装上没有医疗效果信息。有效期印在两种产品上。序列号没有打印在一个产品上。在问卷调查中,护士和药剂师打印标准剂量的期望次数明显高于处方医生和非医护人员。护士们认为有关医疗效果的信息很重要。药剂师要求更多的条形码。卫生保健专业人员要求提供几个识别码。尽管许多药片的尺寸为9毫米,但受访者希望药片更小。结论:包装上打印的信息量与医疗保健专业人员和非医疗保健工作者认为理想的信息量之间存在差距。我们的研究结果表明,多种药物被认为有助于开发未来上市的口服药物包装,并确保安全可靠的药物治疗
{"title":"Investigation of Information Printed on The Blister Pack of Loxoprofen Sodium Tablets","authors":"H. Houchi, Yuuri Houchi","doi":"10.47363/jmhc/2023(5)223","DOIUrl":"https://doi.org/10.47363/jmhc/2023(5)223","url":null,"abstract":"Introduction: Loxoprofen sodium was selected as a commonly used medicine. The loxoprofen sodium tablets are marketed by 22 companies in Japan. The 22 different packaging types for this single active ingredient are served. We investigated the specifications printed on the 10-tablet blister pack. Methods: Regarding specifications printing, using the 22 loxoprofen sodium products, the survey items included how many times each of the specific printing was printed on the 10-tablet blister pack. About the questionnaire survey, a question I assessed the desired number of specifications. Question II assessed the direct printing of the drug name on each of the tablets and the size of tablet. The target population of the survey consisted of prescribing doctors, nurses, pharmacists, and non-healthcare workers. Result: The number of instances in which the drug name was listed ranged from 3 to 22 on the 10-tablet blister pack. The tablet identification code was printed ranged 0 - 10. Eleven products had no medical effect information on the pack. The expiration date was printed on two products. The serial number was not printed on one product. On the questionnaire survey, the desired number of instances that the standard dose was printed was significantly higher for nurses and pharmacists than for prescribing doctors and non-healthcare workers. Nurses considered information about medical effects to be important. Pharmacists demanded more barcodes. Several identification codes were requested by health care professionals. Although many of the tablets were 9 mm in size, the respondents desired smaller tablets. Conclusion: There were gaps between the amount of information printed on the pack and that was considered desirable by healthcare professionals and non-healthcare workers. Our findings indicate that multiple items are considered useful for developing packages for oral drugs marketed in the future as well as in ensuring safe and secure pharmacological therapy","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45167400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Making 1-1 Support Person Centred and an Effective Therapeutic Intervention 使1-1支持以人为中心和有效的治疗干预
Pub Date : 2023-01-31 DOI: 10.47363/jmhc/2023(5)221
S. Brennan, R. Sykes
The use of 1-1 support in care homes within the healthcare system in England and Wales is a recognised protective safeguard. However, it is not without its controversies and conflicts as it can prove to be both a highly restrictive and expensive intervention. This paper will examine the use of 1-1 support within care homes for people who present with behaviours that challenge. It will record the findings from a review of 1-1 support for 23 service users over a 30-month period. It will also make a number of recommendations to make 1-1 support an effective, therapeutic, person centred and a correctly targeted resource.
在英格兰和威尔士的医疗保健系统中,在护理院使用1-1支持是公认的保护措施。然而,它并非没有争议和冲突,因为它可以证明是一种高度限制性和昂贵的干预。本文将研究1-1支持在护理院中对具有挑战行为的人的使用。它将记录在30个月期间对23名服务用户的1-1支持进行审查的结果。它还将提出一些建议,使1-1支持成为一种有效的、治疗性的、以人为本的、目标正确的资源。
{"title":"Making 1-1 Support Person Centred and an Effective Therapeutic Intervention","authors":"S. Brennan, R. Sykes","doi":"10.47363/jmhc/2023(5)221","DOIUrl":"https://doi.org/10.47363/jmhc/2023(5)221","url":null,"abstract":"The use of 1-1 support in care homes within the healthcare system in England and Wales is a recognised protective safeguard. However, it is not without its controversies and conflicts as it can prove to be both a highly restrictive and expensive intervention. This paper will examine the use of 1-1 support within care homes for people who present with behaviours that challenge. It will record the findings from a review of 1-1 support for 23 service users over a 30-month period. It will also make a number of recommendations to make 1-1 support an effective, therapeutic, person centred and a correctly targeted resource.","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42740251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking the Management of Health Human Resources in Light of Social Determinants and Hospital Magnetism 从社会决定因素和医院磁力的角度重新思考卫生人力资源管理
Pub Date : 2023-01-31 DOI: 10.47363/jmhc/2023(5)220
Frank Nduu Nawej
Employment is a social determinant of health whose ambivalence is a well-established fact. Unemployment is therefore detrimental not only to the health of the unemployed but also to that of their families. Research even suggests that they (the unemployed and their family members) would be more likely to die prematurely than others. On the other hand, a safe job is conducive to the good health of the workers, to their well-being and it brings them satisfaction on the professional level. Nevertheless, the ambivalent nature of work means that it can also determine poor health for workers insofar as “the social organization of work, the mode of management and social relations in the workplace have an impact on the health.” This article aims to identify the organizational and social factors that have a negative impact on the health of health workers and in the light of social determinants and hospital magnetism, to propose a nonexhaustive list of recommendations for redesigned health human resource (HHR) management.
就业是健康的一个社会决定因素,其矛盾心理是一个公认的事实。因此,失业不仅对失业者的健康有害,而且对其家庭的健康有害。研究甚至表明,他们(失业者及其家庭成员)比其他人更有可能过早死亡。另一方面,一份安全的工作有利于工人的健康,有利于他们的福祉,并给他们带来专业水平上的满足感。然而,工作的矛盾性质意味着,它也可以决定工人的健康状况不佳,因为“工作的社会组织、管理模式和工作场所的社会关系对健康有影响。“本文旨在确定对卫生工作者健康产生负面影响的组织和社会因素,并根据社会决定因素和医院吸引力,为重新设计卫生人力资源(HHR)管理提出一份非详尽的建议清单。
{"title":"Rethinking the Management of Health Human Resources in Light of Social Determinants and Hospital Magnetism","authors":"Frank Nduu Nawej","doi":"10.47363/jmhc/2023(5)220","DOIUrl":"https://doi.org/10.47363/jmhc/2023(5)220","url":null,"abstract":"Employment is a social determinant of health whose ambivalence is a well-established fact. Unemployment is therefore detrimental not only to the health of the unemployed but also to that of their families. Research even suggests that they (the unemployed and their family members) would be more likely to die prematurely than others. On the other hand, a safe job is conducive to the good health of the workers, to their well-being and it brings them satisfaction on the professional level. Nevertheless, the ambivalent nature of work means that it can also determine poor health for workers insofar as “the social organization of work, the mode of management and social relations in the workplace have an impact on the health.” This article aims to identify the organizational and social factors that have a negative impact on the health of health workers and in the light of social determinants and hospital magnetism, to propose a nonexhaustive list of recommendations for redesigned health human resource (HHR) management.","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43148579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of 4-Week Supplementation of Oat on Body Mass Index, Waist-Hip Ratio and Physical Fitness Performance among Overweight University Students 4周补充燕麦对超重大学生体质指数、腰臀比和体质表现的影响
Pub Date : 2022-12-31 DOI: 10.47363/jmhc/2022(4)218
Chee Ping Fadzel Wong, Hew Huei Sze
Introduction: Overweight has become a serious health problem around the world and it is necessary to find the best strategic to prevent it. Therefore, the objective of this study was to investigate the effects of oat consumption for four weeks on body mass index, waist-hip ratio and physical fitness performance among overweight university students. Methodology: A total of 30 subjects (age: 22.7 ± 1.9 years; body weight: 77.5 ± 16.6 kg; body mass index: 29.8 ± 4.8 kg.m-2) participated in this study. Subjects consumed oat twice a day for four weeks. Anthropometry measurements such as body mass index and waist-hip ratio were measured at pre and post of four week intervention study. Physical fitness performance tests such as push-up, sit-up and plank were also measured at pre and post of four weeks intervention study. Results: This study found there was a signification reduction in body weight and body mass index between pre and post of four weeks intervention study (p<0.05). Body weight and body mass index decreased by 1.16 ± 1.36 kg (1.50%) and 0.46 ± 0.48 kg/m2 (1.54%), respectively. However, there was no significant difference in waist-hip ratio between pre and post of four weeks intervention study (p>0.05). For physical fitness performance tests, there were significant improvements in the push-up, sit-up and plank test between the pre and post of four weeks intervention study (p<0.05). Conclusion: This study found that consumption of oat for four weeks was effective in reducing body weight, body mass index and improving physical fitness performance among overweight university students. However, more researches are still warranted to reconfirm these findings at different population and intervention protocols.
引言:超重已成为世界各地一个严重的健康问题,有必要找到最佳的预防策略。因此,本研究的目的是调查连续四周食用燕麦对超重大学生体重指数、腰臀比和体能表现的影响。方法:共有30名受试者(年龄:22.7±1.9岁;体重:77.5±16.6 kg;体重指数:29.8±4.8 kg.m-2)参与了本研究。受试者连续四周每天食用燕麦两次。在为期四周的干预研究前后测量人体测量,如体重指数和腰臀比。在为期四周的干预研究前后,还测量了俯卧撑、仰卧起坐和平板支撑等体能表现测试。结果:本研究发现,干预研究前后体重和体重指数均有显著下降(p0.05)。在体能表现测试中,俯卧撑有显著改善,结论:本研究发现,在超重大学生中,食用燕麦4周能有效降低体重、体重指数,改善体质。然而,仍有必要进行更多的研究,以在不同的人群和干预方案中再次确认这些发现。
{"title":"Effects of 4-Week Supplementation of Oat on Body Mass Index, Waist-Hip Ratio and Physical Fitness Performance among Overweight University Students","authors":"Chee Ping Fadzel Wong, Hew Huei Sze","doi":"10.47363/jmhc/2022(4)218","DOIUrl":"https://doi.org/10.47363/jmhc/2022(4)218","url":null,"abstract":"Introduction: Overweight has become a serious health problem around the world and it is necessary to find the best strategic to prevent it. Therefore, the objective of this study was to investigate the effects of oat consumption for four weeks on body mass index, waist-hip ratio and physical fitness performance among overweight university students. Methodology: A total of 30 subjects (age: 22.7 ± 1.9 years; body weight: 77.5 ± 16.6 kg; body mass index: 29.8 ± 4.8 kg.m-2) participated in this study. Subjects consumed oat twice a day for four weeks. Anthropometry measurements such as body mass index and waist-hip ratio were measured at pre and post of four week intervention study. Physical fitness performance tests such as push-up, sit-up and plank were also measured at pre and post of four weeks intervention study. Results: This study found there was a signification reduction in body weight and body mass index between pre and post of four weeks intervention study (p<0.05). Body weight and body mass index decreased by 1.16 ± 1.36 kg (1.50%) and 0.46 ± 0.48 kg/m2 (1.54%), respectively. However, there was no significant difference in waist-hip ratio between pre and post of four weeks intervention study (p>0.05). For physical fitness performance tests, there were significant improvements in the push-up, sit-up and plank test between the pre and post of four weeks intervention study (p<0.05). Conclusion: This study found that consumption of oat for four weeks was effective in reducing body weight, body mass index and improving physical fitness performance among overweight university students. However, more researches are still warranted to reconfirm these findings at different population and intervention protocols.","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45570657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Associated with Subspecialty Choice of Cardiology Trainees in the North West of England: Forced by Vacancy or have a Clear Plan of Future? 英格兰西北部心脏病学实习生亚专业选择的相关因素:是迫于职位空缺还是有明确的未来规划?
Pub Date : 2022-12-31 DOI: 10.47363/jmhc/2022(4)219
B. Kunadian, Mumtaz Patel
Aim: Limited information exists on perceptions and professional development preferences on how trainees choose their sub-specialty. This study plan was set up to explore trainee cardiologists’ views of sub-specialty choice, with particular emphasis on career choices. Methods: This study was undertaken using questionnaires – “predetermined” through a web-based survey method. All cardiology trainees in the Health Education England North West (HEE NW) based in Merseyside and Manchester were asked to participate. This study had ethics approval from Edge Hill University and HEE research governance group. Results: The survey was sent to 49 trainees in the region and out of them 32 the completed survey. 25% were females, 66% were in their Specialty Training (ST) ST3-ST5 training, 78% had their under-graduate training in the UK, 94% were full time trainees and 69% were in the 30 to 35-year age group. The stimulating career, positive role model, family friendly and stable hours were found to be the key professional developmental factors in sub-specialty choice. Female friendly was less favored. Interference with family life, intellectually stimulating, and compensation and integration were key perception on sub-specialty choice. Adverse job conditions were not perceived as influential in sub-specialty choice. Prior clinical experience and easy access to training were the other factors influencing the trainee’s choice of sub- specialty. The adverse job conditions including exposure to radiation, unplanned on-calls and long operating time were associated with procedural related sub-specialties. The interference with family life, more financial benefit, positive role models, professional challenges and patient focus were associated with interventional Cardiology. Female friendly, family friendly, stable hours, compensation / integration were associated with imaging sub-specialty. Conclusion: Studying in depth into trainees’ perceptions and preferences may help in any efforts to make sub-specialty choice attractive and also help match work force to demand in the region.
目的:关于受训人员如何选择其子专业的看法和专业发展偏好的信息有限。本研究计划旨在探讨实习心脏病专家对亚专业选择的看法,特别强调职业选择。方法:本研究采用基于网络的调查方法“预先确定”的问卷调查。位于默西塞德郡和曼彻斯特的英格兰西北健康教育中心(HEE NW)的所有心脏病学受训人员都被要求参加。这项研究得到了Edge Hill大学和HEE研究管理小组的伦理批准。结果:该调查发给了该地区49名受训人员,其中32人完成了调查。25%是女性,66%在接受专业培训(ST)ST3-ST5培训,78%在英国接受研究生以下培训,94%是全职学员,69%在30至35岁年龄组。刺激性的职业、积极的榜样、家庭友好和稳定的工作时间是子专业选择的关键专业发展因素。女性友好型则不那么受欢迎。对家庭生活的干扰、智力刺激、补偿和整合是亚专业选择的关键感知。不利的工作条件对亚专业的选择没有影响。先前的临床经验和容易接受培训是影响受训者选择子专业的其他因素。不利的工作条件,包括暴露于辐射、非计划的待命和长时间的操作与程序相关的子专业有关。干预心脏病学与家庭生活的干扰、更多的经济利益、积极的榜样、职业挑战和患者关注有关。女性友好型、家庭友好型、稳定工作时间、补偿/整合与影像学亚专业相关。结论:深入研究受训人员的感知和偏好可能有助于使子专业的选择具有吸引力,也有助于将劳动力与该地区的需求相匹配。
{"title":"Factors Associated with Subspecialty Choice of Cardiology Trainees in the North West of England: Forced by Vacancy or have a Clear Plan of Future?","authors":"B. Kunadian, Mumtaz Patel","doi":"10.47363/jmhc/2022(4)219","DOIUrl":"https://doi.org/10.47363/jmhc/2022(4)219","url":null,"abstract":"Aim: Limited information exists on perceptions and professional development preferences on how trainees choose their sub-specialty. This study plan was set up to explore trainee cardiologists’ views of sub-specialty choice, with particular emphasis on career choices. Methods: This study was undertaken using questionnaires – “predetermined” through a web-based survey method. All cardiology trainees in the Health Education England North West (HEE NW) based in Merseyside and Manchester were asked to participate. This study had ethics approval from Edge Hill University and HEE research governance group. Results: The survey was sent to 49 trainees in the region and out of them 32 the completed survey. 25% were females, 66% were in their Specialty Training (ST) ST3-ST5 training, 78% had their under-graduate training in the UK, 94% were full time trainees and 69% were in the 30 to 35-year age group. The stimulating career, positive role model, family friendly and stable hours were found to be the key professional developmental factors in sub-specialty choice. Female friendly was less favored. Interference with family life, intellectually stimulating, and compensation and integration were key perception on sub-specialty choice. Adverse job conditions were not perceived as influential in sub-specialty choice. Prior clinical experience and easy access to training were the other factors influencing the trainee’s choice of sub- specialty. The adverse job conditions including exposure to radiation, unplanned on-calls and long operating time were associated with procedural related sub-specialties. The interference with family life, more financial benefit, positive role models, professional challenges and patient focus were associated with interventional Cardiology. Female friendly, family friendly, stable hours, compensation / integration were associated with imaging sub-specialty. Conclusion: Studying in depth into trainees’ perceptions and preferences may help in any efforts to make sub-specialty choice attractive and also help match work force to demand in the region.","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42486202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Oral Therapy Based on Ferric Sodium EDTA, in Combination With Vitamin C, Folic Acid, Copper Gluconate, Zinc Gluconate and Selenomethionine, in Iron-Deficiency Anemia: A Real-Life Study 基于EDTA铁钠联合维生素C、叶酸、葡萄糖酸铜、葡萄糖酸锌和硒代蛋氨酸口服治疗缺铁性贫血的评价:一项现实研究
Pub Date : 2022-10-31 DOI: 10.47363/jmhc/2022(4)209
A. Curcio, Antonietta Incarnato
Iron deficiency (ID) and iron-deficiency anemia (IDA) are still frequent conditions in several patients’ settings. Oral iron supplementation is one of available treatments of IDA, representing a convenient strategy since is cost-saving, effective and does not require intravenous (IV) access. However, often traditional oral iron therapies, mainly based on ferrous sulphate, are poorly tolerated, and with low iron absorption, causing gastrointestinal adverse events and limiting adherence to treatment and efficacy. The aim of this study is to evaluate the efficacy and safety of a new oral iron supplementation based on Ferric Sodium EDTA, in combination with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine (Ferachel forte®) for IDA treatment in real-life clinical practice. Patients (N=103) were allocated to treatment with this new formulation at dosage of 1 tab/day, containing 30 mg of iron for 72 days. Patients were evaluated at basal conditions (T0), after 24 and 72 days of therapy (T1 and T2, respectively), collecting blood parameters of hemoglobin (Hb) and sideremia, evaluated as primary objective. The secondary outcomes were symptoms improvement (evaluated through a 4-points score) and safety profile of oral therapy. Treatment with Ferric Sodium EDTA in combination with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine (Ferachel Forte®) showed improvements statistically significant (P < 0.001) of Hb and sideremia levels both at time T1 and T2. Symptoms evaluation showed an almost total resolution of symptomatology after only 72 days of therapy, and treatment was safe and well tolerated. In conclusion, this study confirmed the efficacy and the safety of the new oral iron formulation evaluated, for IDA patients in real-life clinical practice.
在一些患者的环境中,缺铁(ID)和缺铁性贫血(IDA)仍然是常见的情况。口服补铁是IDA的有效治疗方法之一,这是一种方便的策略,因为它节省成本、有效且不需要静脉注射。然而,通常以硫酸亚铁为主的传统口服铁疗法耐受性差,铁吸收率低,会导致胃肠道不良事件,限制治疗的依从性和疗效。本研究的目的是评估一种基于EDTA铁钠、维生素C、叶酸、葡萄糖酸铜、葡萄糖酸锌和硒代蛋氨酸(Ferachel forte®)的新型口服铁补充剂在实际临床实践中治疗IDA的疗效和安全性。将患者(N=103)分配给这种新制剂进行治疗,剂量为1 tab/天,含30mg铁,持续72天。在基础条件(T0)下,在治疗24天和72天后(分别为T1和T2)对患者进行评估,收集血红蛋白(Hb)和菱铁矿血的血液参数,作为主要目标进行评估。次要结果是症状改善(通过4分评估)和口服治疗的安全性。EDTA铁钠与维生素C、叶酸、葡萄糖酸铜、葡萄糖酸锌和硒代蛋氨酸(Ferachel-Forte®)联合治疗显示,在T1和T2时间段,Hb和铁血水平均有统计学意义的改善(P<0.001)。症状评估显示,仅治疗72天后,症状几乎完全缓解,治疗是安全的,耐受性良好。总之,本研究证实了新的口服铁制剂在实际临床实践中对IDA患者的疗效和安全性。
{"title":"Evaluation of Oral Therapy Based on Ferric Sodium EDTA, in Combination With Vitamin C, Folic Acid, Copper Gluconate, Zinc Gluconate and Selenomethionine, in Iron-Deficiency Anemia: A Real-Life Study","authors":"A. Curcio, Antonietta Incarnato","doi":"10.47363/jmhc/2022(4)209","DOIUrl":"https://doi.org/10.47363/jmhc/2022(4)209","url":null,"abstract":"Iron deficiency (ID) and iron-deficiency anemia (IDA) are still frequent conditions in several patients’ settings. Oral iron supplementation is one of available treatments of IDA, representing a convenient strategy since is cost-saving, effective and does not require intravenous (IV) access. However, often traditional oral iron therapies, mainly based on ferrous sulphate, are poorly tolerated, and with low iron absorption, causing gastrointestinal adverse events and limiting adherence to treatment and efficacy. The aim of this study is to evaluate the efficacy and safety of a new oral iron supplementation based on Ferric Sodium EDTA, in combination with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine (Ferachel forte®) for IDA treatment in real-life clinical practice. Patients (N=103) were allocated to treatment with this new formulation at dosage of 1 tab/day, containing 30 mg of iron for 72 days. Patients were evaluated at basal conditions (T0), after 24 and 72 days of therapy (T1 and T2, respectively), collecting blood parameters of hemoglobin (Hb) and sideremia, evaluated as primary objective. The secondary outcomes were symptoms improvement (evaluated through a 4-points score) and safety profile of oral therapy. Treatment with Ferric Sodium EDTA in combination with vitamin C, folic acid, copper gluconate, zinc gluconate and selenomethionine (Ferachel Forte®) showed improvements statistically significant (P < 0.001) of Hb and sideremia levels both at time T1 and T2. Symptoms evaluation showed an almost total resolution of symptomatology after only 72 days of therapy, and treatment was safe and well tolerated. In conclusion, this study confirmed the efficacy and the safety of the new oral iron formulation evaluated, for IDA patients in real-life clinical practice.","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45887794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of medicine and healthcare
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1